Fertility supplement contains nutrients, such as folic acid, fish
oil, selenium, vitamin E, vitamin D, and others to enhance the fertility of
the individuals. Surge in the prevalence of infertility globally and rising
rates of obesity are the key drivers boosting the growth of the market. For
instance, according to the World Health Organization, in 2021, there were
around 48 million couples, and 186 million individuals suffering from
infertility disease globally. Apart from this, an increase in disposable income
and the high adoption of a sedentary lifestyle is also having a positive impact
on the market during the forecast period.
The Fertility
Supplement Market is expected to grow at a steady rate of around 7.8%
during the forecast period (2022-2028). Surge in
the prevalence of infertility globally and rising rates of obesity are the key
drivers boosting the growth of the market. For instance, according to the World
Health Organization, in 2021, there were around 48 million couples, and 186
million individuals suffering from infertility disease globally. Apart from
this, an increase in disposable income and the high adoption of a sedentary
lifestyle is also having a positive impact on the market during the forecast
period.
Unlock The Table of Content, And Request a Research
Report Sample PDF – https://univdatos.com/get-a-free-sample-form-php/?product_id=30030
According to UnivDatos Market Insights
(UMI)’ research report “Global Fertility
Supplement Market”, the market is expected to witness robust growth
during the forecast period (2022-2028). The
growth of the market is driven by factors such as rising incidences of
infertility cases and the emerging trend of delayed pregnancies among women. Apart
from this, the growing prevalence of the smoker population is also propelling
the market’s growth. Even fertility treatments such as in-vitro fertilization
are not helpful in conceiving for smoking women, which has prompted fertility
manufacturers to look for ingredients that can eliminate the effects of smoking
on fertility. For instance, according to the American Society for Reproductive
Medicine, in the U.S., approximately 35% and 30% of men and women of
reproductive age smoke cigarettes.
Based on ingredient,
the market is segmented
into natural and synthetic/blend of natural & synthetic. The synthetic
segment is expected to grow with high CAGR rates during the forecast period.
Several factors such as the high usage of synthetic ingredients including selenium,
folic acid, vitamin B6, COQ10, and zinc due to their easy availability and
increased demand is a key factor driving the growth of the market during the
forecast period.
Based on the product,
the market is categorized
into into capsules, tablets, soft gels, powder, and liquids. The capsule
segment held the dominant share in the market due to wide availability of the
products. Moreover, the companies are rapidly launching new products, which is
another factor propelling the market’s growth. For instance, in 2022, Ovaterra
launched two new prenatal vitamin supplements, Advanced Prenatal and Advanced
Prep 35-39. They are prenatal capsules formulated with the full recommended
daily value of choline for pregnant and nursing women.
For Detailed Analysis On the Topic- Please
Reach Out to Univdatos Team - https://univdatos.com/get-a-free-sample-form-php/?product_id=30030
Based on the end-user,
the fertility supplement market is segmented into men and women. Women held the
maximum share in the global market due to an increase in fertility issues among
married infertile women aged 40 to 44, followed by women aged 35 to 39. For
instance, according to the Centers for Disease Control and Prevention (CDC), in
2021, about 19% of women between 15-49 years of age with no prior births suffer
from infertility issues.
Based on the distribution,
the market is classified as OTC and prescribed. OTC held the majority of the
share in the global market due to its cost-effectiveness and convenience of
direct purchase. Apart from this, the growing trend of self-medication among
individuals is also driving the growth of the segment during the forecast
period.
APAC to witness extensive growth
For a better understanding of the market
adoption of the fertility supplement industry, the market is analyzed based on
its worldwide presence in the countries such as North America (U.S., Canada,
Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of
Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of
World. APAC is anticipated to grow at a substantial CAGR during the forecast
period. This is mainly du due to growing nutritional knowledge in India and China. Other factors,
such as rising disposable income, increasing healthcare expenditure, and a
surge in fertility supplement manufacturers are also driving the growth of the
market in the Asia-Pacific region. In addition to this, the continuous
expansion of the retail market in emerging economies of the region to promote
investments of key manufacturers is anticipated to augment the market growth in
the region.
For More Informative Information, Please Visit
Us – https://univdatos.com/report/fertility-supplement-market/
According to UnivDatos Market Insights (UMI)’,
the key players with a considerable market share in the fertility
supplement market are Fairhaven Health; Coast Science;
Lenus Pharma GesmbH; Bionova; Vitabiotics Ltd.; Orthomol; Exeltis USA, Inc.; The
Bird and Be Co. Inc.; VH Nutrition LLC, and TTK HealthCare Ltd.
“Global
Fertility
Supplement Market” provides comprehensive qualitative and quantitative insights on
the industry potential, key factors impacting sales and purchase decisions,
hotspots, and opportunities available for the market players. Moreover, the
report also encompasses the key strategic imperatives for success for
competitors along with strategic factorial indexing measuring competitors’
capabilities on different parameters. This will help companies in the
formulation of go-to-market strategies and identifying the blue ocean for its
offerings.
Market Segmentation:
1. By
Ingredient (Natural and Synthetic/Blend of Natural & Synthetic)
2. By
Product (Capsules, Tablets, Soft Gels, Powder, and Liquids)
3. By
End User (Men and Women)
4. By
Distribution (OTC and Prescribed)
5. By
Region (North America, Europe, Asia-Pacific, Rest of
the World)
6. By
Company (Fairhaven Health; Coast Science; Lenus Pharma GesmbH; Bionova;
Vitabiotics Ltd.; Orthomol; Exeltis USA, Inc.; The Bird and Be Co. Inc.; VH
Nutrition LLC, and TTK HealthCare Ltd.)
Key
questions answered in the study:
1.
What are the current and future trends
of the global fertility supplement industry?
2.
How the industry has been evolving in
terms of ingredient, product, end-user, and distribution?
3.
How the competition has been shaping
across the countries followed by their comparative factorial indexing?
4.
What are the key growth drivers and
challenges for the global fertility supplement industry?
5.
What is the customer orientation,
purchase behavior, and expectations from the global fertility supplement suppliers
across various region and countries?
Labels: Fertility Supplement Market, univdatos